TG Therapeutics Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
NOVN | Novartis | Hold |
10
|
CHF93.37 | CHF105.00 | 15.26% | 9 | CHF190.51B |
SAN | Sanofi | Outperform |
16
|
89.17€ | 102.80€ | 22.80% | 9 | 111.47€B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | $58.15 | 22.64% | 10 | $89.25B |
MRK | Merck KGaA | Outperform |
18
|
167.20€ | 190.06€ | 6.46% | 4 | 72.69€B |
BIIB | Biogen | Outperform |
10
|
$230.57 | $299.62 | 25.12% | 13 | $33.57B |
BAYN | Bayer | Hold |
5
|
28.58€ | 45.15€ | 4.97% | 4 | 28.08€B |
GMAB | Genmab A/S | Outperform |
16
|
kr2.04k | kr2.71k | 29.35% | 14 | kr131.83B |
TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | $11.59 | 4.36% | 9 | $18.45B |
ALKS | Alkermes | Outperform |
10
|
$24.15 | $33.27 | 32.51% | 3 | $4.11B |